SCM
Soleus Capital Management’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127M | Buy |
922,958
+481,200
| +109% | +$66.1M | 8.4% | 1 |
|
|
2025
Q1 | $79.6M | Buy |
441,758
+83,379
| +23% | +$15M | 5.73% | 3 |
|
|
2024
Q4 | $56.1M | Buy |
358,379
+141,400
| +65% | +$22.2M | 3.53% | 4 |
|
|
2024
Q3 | $39.5M | Buy |
216,979
+90,979
| +72% | +$16.6M | 3.06% | 6 |
|
|
2024
Q2 | $23.1M | Buy |
126,000
+41,900
| +50% | +$7.69M | 2.04% | 13 |
|
|
2024
Q1 | $15M | Buy |
84,100
+44,100
| +110% | +$7.85M | 1.11% | 27 |
|
|
2023
Q4 | $4.96M | Sell |
40,000
-77,892
| -66% | -$9.66M | 0.55% | 44 |
|
|
2023
Q3 | $13.7M | Buy |
117,892
+7,700
| +7% | +$893K | 1.26% | 25 |
|
|
2023
Q2 | $12.9M | Buy |
110,192
+25,013
| +29% | +$2.94M | 1.44% | 20 |
|
|
2023
Q1 | $6.82M | Sell |
85,179
-103,038
| -55% | -$8.25M | 0.71% | 39 |
|
|
2022
Q4 | $14.9M | Sell |
188,217
-19,115
| -9% | -$1.51M | 2.14% | 14 |
|
|
2022
Q3 | $14.5M | Sell |
207,332
-7,150
| -3% | -$498K | 1.96% | 17 |
|
|
2022
Q2 | $14.1M | Sell |
214,482
-74,855
| -26% | -$4.92M | 2.2% | 11 |
|
|
2022
Q1 | $19.3M | Buy |
289,337
+60,900
| +27% | +$4.05M | 2.48% | 10 |
|
|
2021
Q4 | $16M | Buy |
228,437
+102,908
| +82% | +$7.2M | 1.6% | 21 |
|
|
2021
Q3 | $6.55M | Buy |
125,529
+58,000
| +86% | +$3.03M | 1.02% | 29 |
|
|
2021
Q2 | $4.59M | Sell |
67,529
-99,315
| -60% | -$6.75M | 0.71% | 29 |
|
|
2021
Q1 | $12.9M | Buy |
166,844
+156,421
| +1,501% | +$12.1M | 2.32% | 7 |
|
|
2020
Q4 | $625K | Buy |
+10,423
| New | +$625K | 0.08% | 58 |
|